{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 54,
  "pageCount": 110,
  "prevPage": 53,
  "nextPage": 55,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "callout_box",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/54",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-54",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.82,
        "x": 0.09,
        "y": 0.13
      },
      "kind": "callout",
      "text": "Valeant's capital allocation strategy reflects management's focus on creating shareholder value",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98d6dd0f-f71b-4b97-8e62-d556722a251e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.8,
        "x": 0.11,
        "y": 0.2
      },
      "kind": "list",
      "text": "Acquisitions: Management has completed 100+ acquisitions and licenses, investing $19bn+ since 2008. These acquisitions have been highly accretive due to superior cost structure and operating model. Valeant management expects the majority of the company's future free cash flow will be allocated to its value-creating acquisition strategy.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cc3bece-2461-4a53-9eb3-4ec6a2386d95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.11,
        "y": 0.41
      },
      "kind": "list",
      "text": "Share Repurchases: Valeant has been an aggressive buyer of its stock. Between 2008 and 2012, Valeant repurchased $2.5bn of stock and convertible bonds.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "469aa7d3-2a5a-4bcb-a94f-7c5256c21cf5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "acquisitions: $19bn+",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-f5d4-752d-aacf-fbcc413060f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.15,
        "x": 0.09,
        "y": 0.51
      },
      "kind": "source-note",
      "text": "Source: Management Interviews",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ba5e986-689a-4b3f-bc8b-2388b9cebca6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.09,
        "y": 0.09
      },
      "kind": "title",
      "text": "Capital Allocation at Valeant",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c2bfd21-20da-43ac-b499-95d59d8fb8c6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Capital Allocation Framework",
      "slug": "capital-allocation-framework",
      "agent": null,
      "layer": "slide",
      "matchId": "9bf0fb23-bfe7-4141-8cd8-8049ed7892bc",
      "evidence": "Valeant's capital allocation strategy reflects management's focus on creating shareholder value",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "capital-allocation-framework",
      "slug": null,
      "matchId": "346d1f88-a014-4a3f-bfb4-fbf361af9bc8",
      "evidence": "The slide explicitly categorizes capital allocation into acquisitions and share repurchases.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}